# Platelet-rich plasma for the treatment of postoperative anastomotic fistula of the gastrointestinal tract: a case report

**Authors:** Sihui Jia, Yawen Guo, Changkai Zhang, Xiaoyuan Sun, Licun Wang, Haiyan Wang

PMC · DOI: 10.3389/fphar.2026.1727021 · Frontiers in Pharmacology · 2026-02-11

## TL;DR

This case report shows that platelet-rich plasma (PRP) gel can effectively heal a persistent gastrointestinal anastomotic fistula after surgery.

## Contribution

The novel use of PRP gel for treating a non-healing anastomotic fistula is demonstrated in a clinical case.

## Key findings

- PRP gel was successfully used to occlude an anastomotic fistula under gastroscopy.
- The fistula healed completely within one week after PRP treatment.
- PRP offers a potential alternative for fistulas unresponsive to conservative therapy.

## Abstract

Anastomotic fistulas are a possible complication of local digestive tract resections, and their main symptoms include abdominal pain, peritonitis, and infections. Currently, the treatment of anastomotic fistulas is primarily conservative or involves surgical repair. Platelet-rich plasma (PRP) contains high concentrations of platelets and is used to promote wound healing. However, the use of PRP in the treatment of anastomotic fistulas has rarely been reported.

The patient was a 63 year-old man, Chinese and Asian. The patient underwent radical treatment for a malignant colon tumor in 2011. In 2014, he complained of persistent abdominal pain and was diagnosed with a malignant gastric tumor for which he underwent a subtotal (Billroth I) gastrectomy. After the surgery, an anastomotic fistula was observed. After more than 1 month of conservative treatment, the patient’s anastomotic fistula still failed to heal; then, autologous PRP was attempted. PRP was prepared by centrifugation and activated into a gel state. The fistula was treated with PRP gel occlusion endoscopically, and a total of 3 mL was injected. One week after treatment, the fistula was healed.

Anastomotic fistula after subtotal gastrectomy.

Platelet-rich plasma (PRP) gel occluded anastomotic fistula under gastroscopy.

One week after PRP treatment, the closure of the fistula was observed.

PRP derived from the patient’s own blood, offers advantages for healing intestinal fistulas that fail to respond to prolonged conservative therapy. Injecting PRP gel directly into these fistulas promotes tissue regeneration and closure.

## Linked entities

- **Diseases:** malignant colon tumor (MONDO:0021063), malignant gastric tumor (MONDO:0001056)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, C4BPA (complement component 4 binding protein alpha) [NCBI Gene 722] {aka C4BP, PRP}, PF4 (platelet factor 4) [NCBI Gene 5196] {aka CXCL4, PF-4, SCYB4}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, F2 (coagulation factor II, thrombin) [NCBI Gene 280685], PPBP (pro-platelet basic protein) [NCBI Gene 5473] {aka B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}
- **Diseases:** infections (MESH:D007239), skin ulcers (MESH:D012883), adenocarcinoma (MESH:D000230), peritonitis (MESH:D010538), malignant (MESH:D009369), gastrointestinal fistula (MESH:D005767), rupture (MESH:D012421), chronic diabetes mellitus (MESH:D003920), abdominal pain (MESH:D015746), anastomotic leakage (MESH:D057868), vascular injury (MESH:D057772), intraepithelial neoplasia (MESH:D002578), edema (MESH:D004487), chronic mucosal inflammation (MESH:D007249), abscess (MESH:D000038), finger trauma (MESH:D014947), muscle tension (MESH:D018781), acid reflux (MESH:D005764), hematomas (MESH:D006406), hyperglycemic (MESH:D006944), hematological disorders (MESH:D006402), fracture (MESH:D050723), pain (MESH:D010146), bronchial fistula (MESH:D001983), abdominal cavity infection (MESH:D000008), colon cancer (MESH:D015179), osteoarthritis (MESH:D010003), Anastomotic fistulas (MESH:D005402), fever (MESH:D005334), intestinal fistulas (MESH:D007412), vomiting (MESH:D014839), colon tumor (MESH:D003110), nausea (MESH:D009325), gastric adenocarcinoma (MESH:D013274), perforation (MESH:D057112), scars (MESH:D002921), heartburn (MESH:D006356), hyperemia (MESH:D006940), rebound tenderness (MESH:D063806)
- **Chemicals:** CTAP-III (MESH:C009862), sodium citrate (MESH:D000077559), calcium chloride (MESH:D002122), PGFs (MESH:D011460), blood glucose (MESH:D001786), CO2 (MESH:D002245)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932979/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932979/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932979/full.md

---
Source: https://tomesphere.com/paper/PMC12932979